Schonfeld Strategic Advisors’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28,000	Closed	-$282K	–	2961
2022 Q4	$282K	Hold	28,000	–	–	﹤0.01%	1824
2022 Q3	$277K	Sell	28,000 -16,915	-38%	-$167K	﹤0.01%	2133
2022 Q2	$439K	Buy	44,915 +5,151	+13%	+$50.5K	﹤0.01%	1437
2022 Q1	$389K	Sell	39,764 -236	-0.6%	-$2.3K	﹤0.01%	1528
2021 Q4	$389K	Hold	40,000	–	–	﹤0.01%	1400
2021 Q3	$390K	Buy	40,000 +20,000	+100%	+$193K	﹤0.01%	1394
2021 Q2	$193K	Buy	+20,000	New	+$195K	﹤0.01%	1688

Schonfeld Strategic Advisors's MSAC Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 28,000 shares — an estimated $282K sold.

Schonfeld Strategic Advisors first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $439K in Q2 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Schonfeld Strategic Advisors reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 28,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $282K.
Schonfeld Strategic Advisors first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Schonfeld Strategic Advisors's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $439K in Q2 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.